Leadership change at Piramal Critical Care: Jeffrey Hampton to retire, Brian Guy appointed President & COO

Jeffrey Hampton, President & COO of Piramal Critical Care, retires from service at close of business on 27th November, 2026 and ceases to be Senior Management Personnel.

Wed 30 Sep 2026

Retiring Executive

Jeffrey Hampton, President & COO of Piramal Critical Care

Retirement Effective Date

27th November, 2026

New Executive Appointee

Brian Guy as President & COO, Piramal Critical Care

New Appointment Effective Date

19th October, 2026

Experience of Appointee

Over 25 years of pharma industry experience

What changed

• Jeffrey Hampton, President and COO, Piramal Critical Care, retires from the services of the Company with effect from close of business hours on 27th November, 2026 and ceases to be Senior Management Personnel from that date.
• The Board, based on the Nomination and Remuneration Committee's recommendation, on 30th September, 2026 approved the appointment of Brian Guy as President and COO, Piramal Critical Care, and as Senior Management Personnel, with effect from 19th October, 2026.

About the incoming appointee

• Over 25 years of experience in business leadership, commercial operations, strategy execution and enterprise management in pharma.
• Currently President & Chief Commercial Officer of Breckenridge Pharmaceutical, Inc., a subsidiary of Towa Pharmaceutical Co., Ltd., with full U.S. P&L responsibility since 2018.
• Experience across portfolio development, strategic partnerships and organizational transformation; played a key role in the sale of Breckenridge Pharmaceutical to Towa Pharmaceutical in 2020. Earlier was Director - Business Development at Aveva Drug Delivery Systems, Inc.
• Holds an MBA (University of Dayton), Master of Science in Administration (Central Michigan University) and B.S. in Psychology (Wright State University).
• Not related to any Director of the Company.

What it means for investors

This is a senior management transition in the Critical Care business, with overlap between the incoming appointee's start date and the outgoing executive's retirement date. The Company states he will work on growth and expansion of the Complex Hospital Generics business. It is a governance and disclosure event rather than a change in financial position.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.